volume 25 number 9 september 2007 (Nature Biotechnology)
90
Structured Review
Nature Biotechnology
volume 25 number 9 september 2007
Volume 25 Number 9 September 2007, supplied by Nature Biotechnology, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/volume+25+number+9+september+2007/volume+25+number+9+september+2007/pm17846628-0-4-6
Average 90 stars, based on 1 article reviews
Volume 25 Number 9 September 2007, supplied by Nature Biotechnology, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/volume+25+number+9+september+2007/volume+25+number+9+september+2007/pm17846628-0-4-6
Average 90 stars, based on 1 article reviews
volume 25 number 9 september 2007 - by Bioz Stars,
2026-09
90/100 stars
Images
Related Articles
Binding Assay:Article Title: Quantitative chemical proteomics reveals mechanisms of action of clinical ABL kinase inhibitors. Article Snippet: We describe a chemical proteomics approach to profile the interaction of small molecules with hundreds of endogenously expressed protein kinases and purine-binding proteins.. This subproteome is captured by immobilized nonselective kinase inhibitors (kinobeads), and the bound proteins are quantified in parallel by mass spectrometry using isobaric tags for relative and absolute quantification (iTRAQ).. By measuring the competition with the affinity matrix, we assess the binding of drugs to their targets in cell lysates and in cells. Article Title: Gene patents and genetic testing in the United States. Article Snippet: Roger D. Klein is at the H. Lee Moffitt Cancer Center & Research Institute and the Department of Interdisciplinary Oncology, University of South Florida Medical School, 12902 Magnolia Drive, Tampa, Florida 33612, USA. e-mail: roger.klein@moffitt.org Molecular genetic testing has increasingly been incorporated into clinical medicine, and this trend is likely to accelerate in the future1,2.. However, the introduction of genetic testing into medical practice is beginning to collide head on with patents that claim ownership of correlations between human genetic variants and predisposition to disease, response to therapeutic drugs and susceptibility to pharmacologic side effects.. Holders or licensees of patents on genes, genetic variants and their biological correlations are already using the threat of litigation to prevent pathologists and other laboratory professionals from performing clinical, diagnostic molecular genetic tests3. Article Title: Recent patent applications in stem cell culture. Article Snippet: Article Title: Trends in biotech literature 2006. Article Snippet: Article Title: On the iTRAQ of kinase inhibitors. Article Snippet: VOLUME 25 NUMBER 9 SEPTEMBER 2007 NATURE BIOTECHNOLOGY comparable, however.. For example, although the Mummery study documented retention of GFP-expressing cells in the infarcted hearts 12 weeks after injury, cardiomyocyte content was not measured.. In addition, the Mummery study did not use pro-survival reagents, and it is possible that death of donor cardiomyocytes contributed to the progressive deterioration of cardiac function observed 12 weeks after injury. Article Title: Comparative analysis of the complete genome sequence of the plant growth-promoting bacterium Bacillus amyloliquefaciens FZB42. Article Snippet: 1014 VOLUME 25 NUMBER 9 Article Title: NIH forges R&D partnerships in developing countries. Article Snippet: VOLUME 25 NUMBER 9 SEPTEMBER 2007 NATURE BIOTECHNOLOGY Strasbourg, France, 2006).. Centrifugation:Article Title: Quantitative chemical proteomics reveals mechanisms of action of clinical ABL kinase inhibitors. Article Snippet: We describe a chemical proteomics approach to profile the interaction of small molecules with hundreds of endogenously expressed protein kinases and purine-binding proteins.. This subproteome is captured by immobilized nonselective kinase inhibitors (kinobeads), and the bound proteins are quantified in parallel by mass spectrometry using isobaric tags for relative and absolute quantification (iTRAQ).. By measuring the competition with the affinity matrix, we assess the binding of drugs to their targets in cell lysates and in cells. Article Title: Gene patents and genetic testing in the United States. Article Snippet: Roger D. Klein is at the H. Lee Moffitt Cancer Center & Research Institute and the Department of Interdisciplinary Oncology, University of South Florida Medical School, 12902 Magnolia Drive, Tampa, Florida 33612, USA. e-mail: roger.klein@moffitt.org Molecular genetic testing has increasingly been incorporated into clinical medicine, and this trend is likely to accelerate in the future1,2.. However, the introduction of genetic testing into medical practice is beginning to collide head on with patents that claim ownership of correlations between human genetic variants and predisposition to disease, response to therapeutic drugs and susceptibility to pharmacologic side effects.. Holders or licensees of patents on genes, genetic variants and their biological correlations are already using the threat of litigation to prevent pathologists and other laboratory professionals from performing clinical, diagnostic molecular genetic tests3. Article Title: Recent patent applications in stem cell culture. Article Snippet: Article Title: Trends in biotech literature 2006. Article Snippet: Article Title: On the iTRAQ of kinase inhibitors. Article Snippet: VOLUME 25 NUMBER 9 SEPTEMBER 2007 NATURE BIOTECHNOLOGY comparable, however.. For example, although the Mummery study documented retention of GFP-expressing cells in the infarcted hearts 12 weeks after injury, cardiomyocyte content was not measured.. In addition, the Mummery study did not use pro-survival reagents, and it is possible that death of donor cardiomyocytes contributed to the progressive deterioration of cardiac function observed 12 weeks after injury. Article Title: Comparative analysis of the complete genome sequence of the plant growth-promoting bacterium Bacillus amyloliquefaciens FZB42. Article Snippet: 1014 VOLUME 25 NUMBER 9 Article Title: NIH forges R&D partnerships in developing countries. Article Snippet: VOLUME 25 NUMBER 9 SEPTEMBER 2007 NATURE BIOTECHNOLOGY Strasbourg, France, 2006).. Protein Concentration:Article Title: Quantitative chemical proteomics reveals mechanisms of action of clinical ABL kinase inhibitors. Article Snippet: We describe a chemical proteomics approach to profile the interaction of small molecules with hundreds of endogenously expressed protein kinases and purine-binding proteins.. This subproteome is captured by immobilized nonselective kinase inhibitors (kinobeads), and the bound proteins are quantified in parallel by mass spectrometry using isobaric tags for relative and absolute quantification (iTRAQ).. By measuring the competition with the affinity matrix, we assess the binding of drugs to their targets in cell lysates and in cells. Article Title: Gene patents and genetic testing in the United States. Article Snippet: Roger D. Klein is at the H. Lee Moffitt Cancer Center & Research Institute and the Department of Interdisciplinary Oncology, University of South Florida Medical School, 12902 Magnolia Drive, Tampa, Florida 33612, USA. e-mail: roger.klein@moffitt.org Molecular genetic testing has increasingly been incorporated into clinical medicine, and this trend is likely to accelerate in the future1,2.. However, the introduction of genetic testing into medical practice is beginning to collide head on with patents that claim ownership of correlations between human genetic variants and predisposition to disease, response to therapeutic drugs and susceptibility to pharmacologic side effects.. Holders or licensees of patents on genes, genetic variants and their biological correlations are already using the threat of litigation to prevent pathologists and other laboratory professionals from performing clinical, diagnostic molecular genetic tests3. Article Title: Recent patent applications in stem cell culture. Article Snippet: Article Title: Trends in biotech literature 2006. Article Snippet: Article Title: On the iTRAQ of kinase inhibitors. Article Snippet: VOLUME 25 NUMBER 9 SEPTEMBER 2007 NATURE BIOTECHNOLOGY comparable, however.. For example, although the Mummery study documented retention of GFP-expressing cells in the infarcted hearts 12 weeks after injury, cardiomyocyte content was not measured.. In addition, the Mummery study did not use pro-survival reagents, and it is possible that death of donor cardiomyocytes contributed to the progressive deterioration of cardiac function observed 12 weeks after injury. Article Title: Comparative analysis of the complete genome sequence of the plant growth-promoting bacterium Bacillus amyloliquefaciens FZB42. Article Snippet: 1014 VOLUME 25 NUMBER 9 Article Title: NIH forges R&D partnerships in developing countries. Article Snippet: VOLUME 25 NUMBER 9 SEPTEMBER 2007 NATURE BIOTECHNOLOGY Strasbourg, France, 2006).. Bradford Assay:Article Title: Quantitative chemical proteomics reveals mechanisms of action of clinical ABL kinase inhibitors. Article Snippet: We describe a chemical proteomics approach to profile the interaction of small molecules with hundreds of endogenously expressed protein kinases and purine-binding proteins.. This subproteome is captured by immobilized nonselective kinase inhibitors (kinobeads), and the bound proteins are quantified in parallel by mass spectrometry using isobaric tags for relative and absolute quantification (iTRAQ).. By measuring the competition with the affinity matrix, we assess the binding of drugs to their targets in cell lysates and in cells. Article Title: Gene patents and genetic testing in the United States. Article Snippet: Roger D. Klein is at the H. Lee Moffitt Cancer Center & Research Institute and the Department of Interdisciplinary Oncology, University of South Florida Medical School, 12902 Magnolia Drive, Tampa, Florida 33612, USA. e-mail: roger.klein@moffitt.org Molecular genetic testing has increasingly been incorporated into clinical medicine, and this trend is likely to accelerate in the future1,2.. However, the introduction of genetic testing into medical practice is beginning to collide head on with patents that claim ownership of correlations between human genetic variants and predisposition to disease, response to therapeutic drugs and susceptibility to pharmacologic side effects.. Holders or licensees of patents on genes, genetic variants and their biological correlations are already using the threat of litigation to prevent pathologists and other laboratory professionals from performing clinical, diagnostic molecular genetic tests3. Article Title: Recent patent applications in stem cell culture. Article Snippet: Article Title: Trends in biotech literature 2006. Article Snippet: Article Title: On the iTRAQ of kinase inhibitors. Article Snippet: VOLUME 25 NUMBER 9 SEPTEMBER 2007 NATURE BIOTECHNOLOGY comparable, however.. For example, although the Mummery study documented retention of GFP-expressing cells in the infarcted hearts 12 weeks after injury, cardiomyocyte content was not measured.. In addition, the Mummery study did not use pro-survival reagents, and it is possible that death of donor cardiomyocytes contributed to the progressive deterioration of cardiac function observed 12 weeks after injury. Article Title: Comparative analysis of the complete genome sequence of the plant growth-promoting bacterium Bacillus amyloliquefaciens FZB42. Article Snippet: 1014 VOLUME 25 NUMBER 9 Article Title: NIH forges R&D partnerships in developing countries. Article Snippet: VOLUME 25 NUMBER 9 SEPTEMBER 2007 NATURE BIOTECHNOLOGY Strasbourg, France, 2006).. Functional Assay:Article Title: Quantitative chemical proteomics reveals mechanisms of action of clinical ABL kinase inhibitors. Article Snippet: We describe a chemical proteomics approach to profile the interaction of small molecules with hundreds of endogenously expressed protein kinases and purine-binding proteins.. This subproteome is captured by immobilized nonselective kinase inhibitors (kinobeads), and the bound proteins are quantified in parallel by mass spectrometry using isobaric tags for relative and absolute quantification (iTRAQ).. By measuring the competition with the affinity matrix, we assess the binding of drugs to their targets in cell lysates and in cells. Article Title: Gene patents and genetic testing in the United States. Article Snippet: Roger D. Klein is at the H. Lee Moffitt Cancer Center & Research Institute and the Department of Interdisciplinary Oncology, University of South Florida Medical School, 12902 Magnolia Drive, Tampa, Florida 33612, USA. e-mail: roger.klein@moffitt.org Molecular genetic testing has increasingly been incorporated into clinical medicine, and this trend is likely to accelerate in the future1,2.. However, the introduction of genetic testing into medical practice is beginning to collide head on with patents that claim ownership of correlations between human genetic variants and predisposition to disease, response to therapeutic drugs and susceptibility to pharmacologic side effects.. Holders or licensees of patents on genes, genetic variants and their biological correlations are already using the threat of litigation to prevent pathologists and other laboratory professionals from performing clinical, diagnostic molecular genetic tests3. Article Title: Recent patent applications in stem cell culture. Article Snippet: Article Title: Trends in biotech literature 2006. Article Snippet: Article Title: On the iTRAQ of kinase inhibitors. Article Snippet: VOLUME 25 NUMBER 9 SEPTEMBER 2007 NATURE BIOTECHNOLOGY comparable, however.. For example, although the Mummery study documented retention of GFP-expressing cells in the infarcted hearts 12 weeks after injury, cardiomyocyte content was not measured.. In addition, the Mummery study did not use pro-survival reagents, and it is possible that death of donor cardiomyocytes contributed to the progressive deterioration of cardiac function observed 12 weeks after injury. Article Title: Comparative analysis of the complete genome sequence of the plant growth-promoting bacterium Bacillus amyloliquefaciens FZB42. Article Snippet: 1014 VOLUME 25 NUMBER 9 Article Title: NIH forges R&D partnerships in developing countries. Article Snippet: VOLUME 25 NUMBER 9 SEPTEMBER 2007 NATURE BIOTECHNOLOGY Strasbourg, France, 2006).. |